New Web site explains how AAT differs from COPD
A new Web site has come on-line at www.beyondcopd.com/ http://www.beyondcopd.com/. to raise awareness of alpha1-antitrypsin deficiency (AAT), which can be confused with chronic obstructive pulmonary disease (COPD). AAT is a genetic lung disease characterized by low AAT protein in the blood; the protein protects the lungs from damaging enzymes released by white blood cells. The American Lung Association estimates that 100,000 Americans have AAT, but 95% of cases are undiagnosed. The Web site is hosted by Baxter, maker of Aralast for the treatment of AAT.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
